| Members |
targetComponentId |
| Epithelial ovarian tumour, FIGO stage IVA (finding) |
American Joint Committee on Cancer stage IVA (qualifier value) |
| Epithelial ovarian tumor, FIGO stage IVB |
IVB |
| Epithelial stromal corneal dystrophy |
Epithelial basement membrane dystrophy (disorder) |
| Epithelial tumor, benign, no International Classification of Diseases for Oncology subtype (morphologic abnormality) |
Benign epithelial neoplasm |
| Epithelioid hemangioendothelioma |
Epithelioid haemangioendothelioma |
| Epoetin alfa 10000unt/mL injection (product) |
Product containing precisely epoetin alfa 10000 unit/1 milliliter conventional release solution for injection (clinical drug) |
| Epoetin alfa 10000unt/mL injection solution 1mL vial (product) |
Product containing precisely epoetin alfa 10000 unit/1 milliliter conventional release solution for injection (clinical drug) |
| Epoetin alfa 10000unt/mL solution (product) |
Product containing precisely epoetin alfa 10000 unit/1 milliliter conventional release solution for injection (clinical drug) |
| Epoetin alfa 20000unt/mL injection solution 1mL vial (product) |
Epoetin alfa 20000 unit/mL solution for injection |
| Epoetin alfa 2000unt/mL injection (product) |
Epoetin alfa 2000 unit/mL solution for injection |
| Epoetin alfa 2000unt/mL injection solution 1mL vial (product) |
Epoetin alfa 2000 unit/mL solution for injection |
| Epoetin alfa 2000unt/mL solution (product) |
Epoetin alfa 2000 unit/mL solution for injection |
| Epoetin alfa 3000unt/mL injection solution 1mL vial (product) |
Product containing precisely epoetin alfa 3000 unit/1 milliliter conventional release solution for injection (clinical drug) |
| Epoetin alfa 4000unt/mL injection solution 1mL vial (product) |
Epoetin alfa 4000 unit/mL solution for injection |
| Epoetin alfa 4000unt/mL solution (product) |
Epoetin alfa 4000 unit/mL solution for injection |
| Epoetin beta 10,000iu powder and solvent for injection solution cartridge (product) |
Epoetin beta only product in parenteral dose form |
| Epoetin beta 10,000iu powder for conventional release solution for injection cartridge |
Epoetin beta only product in parenteral dose form |
| Epoetin beta 100,000iu powder and solvent for injection solution vial (product) |
Epoetin beta only product in parenteral dose form |
| Epoetin beta 100,000iu powder for conventional release solution for injection vial (product) |
Epoetin beta only product in parenteral dose form |
| Epoetin beta 20,000iu powder and solvent for injection solution cartridge (product) |
Epoetin beta only product in parenteral dose form |
| Epoetin beta 20,000iu powder for conventional release solution for injection cartridge (product) |
Epoetin beta only product in parenteral dose form |
| Epoetin beta 50,000iu powder and solvent for injection solution vial (product) |
Epoetin beta only product in parenteral dose form |
| Epoetin beta 50,000iu powder for conventional release solution for injection vial |
Epoetin beta only product in parenteral dose form |
| Epoetin beta 500iu powder and solvent for injection solution vial (product) |
Epoetin beta only product in parenteral dose form |
| Epoetin beta 60,000iu powder and solvent for injection solution cartridge (product) |
Epoetin beta only product in parenteral dose form |
| Epoetin beta 60,000iu powder for conventional release solution for injection cartridge (product) |
Epoetin beta only product in parenteral dose form |
| Epoophoron |
Wolffian body rest |
| Epstein syndrome |
MYH9 related disease |
| Eptifibatide 0.75mg injection (product) |
Product containing precisely eptifibatide 750 microgram/1 milliliter conventional release solution for injection (clinical drug) |
| Eptifibatide 0.75mg/mL injection (product) |
Product containing precisely eptifibatide 750 microgram/1 milliliter conventional release solution for injection (clinical drug) |
| Eptifibatide 0.75mg/mL injection solution 100mL bag (product) |
Product containing precisely eptifibatide 750 microgram/1 milliliter conventional release solution for injection (clinical drug) |
| Equine anti-human thymocyte immunoglobulin 20mg/mL injection solution 5mL vial (product) |
Product containing precisely equine antithymocyte immunoglobulin 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Equus asinus asinus |
Equus asinus |
| Erdheim-Chester disease (morphologic abnormality) |
Polyostotic sclerosing histiocytosis |
| Ergonovine maleate 200mcg/mL injection solution ampule (product) |
Product containing precisely ergometrine 200 microgram/1 milliliter conventional release solution for injection (clinical drug) |
| Ergot compound allergy |
Allergy to ergot alkaloid (finding) |
| Eribulin mesylate 0.5mg/mL conventional release solution for injection (product) |
Product containing only eribulin in parenteral dose form (medicinal product form) |
| Eribulin mesylate 0.5mg/mL solution for intravenous infusion (product) |
Product containing only eribulin in parenteral dose form (medicinal product form) |
| Ertapenem 1g powder for infusion solution vial (product) |
Ertapenem (as ertapenem sodium) 1 g powder for solution for injection vial |
| Erwinia ananas |
Pantoea ananatis (organism) |
| Erwinia cacticida |
Pectobacterium cacticida |
| Erwinia cancerogena (organism) |
Enterobacter cancerogenus |
| Erwinia carnegieana |
Genus Dickeya (organism) |
| Erwinia carotovora |
Pectobacterium carotovorum (organism) |
| Erwinia carotovora ss. atroseptica |
Pectobacterium atrosepticum (organism) |
| Erwinia carotovora ss. betavasculorum |
Pectobacterium betavasculorum (organism) |
| Erwinia carotovora ss. carotovora |
Pectobacterium carotovorum subspecies carotovorum (organism) |
| Erwinia carotovora subsp odorifera |
Pectobacterium carotovorum subspecies odoriferum (organism) |
| Erwinia cartovora subsp cartobora |
Pectobacterium carotovorum subspecies carotovorum (organism) |
| Erwinia cartovora subsp wasabiae |
Pectobacterium wasabiae |
| Erwinia chrysanthemi |
Dickeya chrysanthemi |
| Erwinia cypripedii (organism) |
Pantoea cypripedii (organism) |
| Erwinia herbicola (organism) |
Pantoea agglomerans |
| Erwinia nigrifluens |
Brenneria nigrifluens |
| Erwinia paradisiaca |
Dickeya paradisiaca (organism) |
| Erwinia quercina |
Lonsdalea quercina (organism) |
| Erwinia rhapontici (organism) |
Pectobacterium rhapontici (organism) |
| Erwinia rubrifaciens |
Brenneria rubrifaciens |
| Erwinia salicis |
Brenneria salicis (organism) |
| Erwinia stewartii |
Pantoea stewartii subsp stewartii |
| Erwinia uredovora |
Pantoea ananatis (organism) |
| Erythema infectiosum virus |
Primate erythroparvovirus 1 (organism) |
| Erythromycin 250mg e/c granules in capsule (product) |
Product containing precisely erythromycin 250 milligram/1 each conventional release oral capsule (clinical drug) |
| Erythromycin 250mg gastro-resistant oral capsule (product) |
Product containing precisely erythromycin 250 milligram/1 each conventional release oral capsule (clinical drug) |
| Erythromycin 250mg m/r capsule (product) |
Product containing precisely erythromycin 250 milligram/1 each conventional release oral capsule (clinical drug) |
| Erythromycin ethylsuccinate 100 mg/2.5mL (product) |
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 40 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Erythromycin ethylsuccinate 100mg/2.5mL oral suspension (product) |
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 40 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Erythromycin ethylsuccinate 100mg/2.5mL suspension (product) |
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 40 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Erythromycin ethylsuccinate 200mg/5mL (product) |
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 40 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Erythromycin ethylsuccinate 200mg/5mL liquid (product) |
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 40 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Erythromycin ethylsuccinate 200mg/5mL oral suspension (product) |
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 40 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Erythromycin ethylsuccinate 200mg/5mL suspension (product) |
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 40 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Erythromycin ethylsuccinate 400mg film (product) |
Erythromycin (as erythromycin ethylsuccinate) 400 mg oral tablet |
| Erythromycin ethylsuccinate 400mg/5 mL (product) |
Erythromycin (as erythromycin ethylsuccinate) 80 mg/mL oral suspension |
| Erythromycin ethylsuccinate 400mg/5mL oral suspension (product) |
Erythromycin (as erythromycin ethylsuccinate) 80 mg/mL oral suspension |
| Erythromycin ethylsuccinate 400mg/5mL powder (product) |
Erythromycin (as erythromycin ethylsuccinate) 80 mg/mL oral suspension |
| Erythromycin ethylsuccinate 400mg/5mL suspension (product) |
Erythromycin (as erythromycin ethylsuccinate) 80 mg/mL oral suspension |
| Erythromycin lactobionate 1g injection (product) |
Product containing only erythromycin in parenteral dose form (medicinal product form) |
| Erythromycin lactobionate 1g powder for infusion solution vial (product) |
Product containing only erythromycin in parenteral dose form (medicinal product form) |
| Erythromycin lactobionate 500mg (product) |
Product containing precisely erythromycin (as erythromycin lactobionate) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
| Erythromycin lactobionate 500mg injection (product) |
Product containing precisely erythromycin (as erythromycin lactobionate) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
| Erythromycin lactobionate 500mg powder for infusion solution vial (product) |
Product containing precisely erythromycin (as erythromycin lactobionate) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
| Erythromycin lactobionate 500mg/mL injection (product) |
Product containing precisely erythromycin (as erythromycin lactobionate) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
| Escherichia coli serogroup H (organism) |
Escherichia coli serogroup O undetermined:H (organism) |
| Escherichia coli serogroup H19 (organism) |
Escherichia coli serogroup O undetermined:H19 (organism) |
| Escherichia coli serotype O7:H157 |
Escherichia coli serotype O157:H7 |
| Eserine sulfate 1.0% eye drops (product) |
Product containing precisely physostigmine sulfate 10 milligram/1 milliliter conventional release eye solution (clinical drug) |
| Esmolol hydrochloride 10mg/mL infusion solution (product) |
Product containing only esmolol in parenteral dose form (medicinal product form) |
| Esmolol hydrochloride 10mg/mL injection solution ampule (product) |
Product containing only esmolol in parenteral dose form (medicinal product form) |
| Esmolol hydrochloride 250mg/mL injection solution ampule (product) |
Esmolol hydrochloride 250 mg/mL solution for injection |
| Esomeprazole 20mg delayed release oral suspension (product) |
Product containing precisely esomeprazole (as esomeprazole magnesium) 20 milligram/1 sachet granules for conventional release oral suspension (clinical drug) |
| Esomeprazole 40mg delayed release oral suspension (product) |
Product containing precisely esomeprazole 40 milligram/1 sachet granules for conventional release oral suspension (clinical drug) |
| Esomeprazole magnesium 20mg + naproxen 375mg delayed release tablet (product) |
Product containing precisely esomeprazole (as esomeprazole magnesium) 20 milligram and naproxen (as naproxen sodium) 375 milligram/1 each gastro-resistant oral tablet (clinical drug) |
| Esomeprazole magnesium 20mg + naproxen 500mg delayed release tablet (product) |
Product containing precisely esomeprazole (as esomeprazole magnesium) 20 milligram and naproxen 500 milligram/1 each gastro-resistant oral tablet (clinical drug) |
| Esomeprazole magnesium 20mg gastro-resistant oral capsule (product) |
Esomeprazole (as esomeprazole magnesium) 20 mg oral capsule |
| Esomeprazole magnesium 20mg m/r capsule (product) |
Esomeprazole (as esomeprazole magnesium) 20 mg oral capsule |
| Esomeprazole magnesium 40mg gastro-resistant oral capsule |
Esomeprazole (as esomeprazole magnesium) 40 mg oral capsule |
| Esomeprazole magnesium 40mg m/r capsule (product) |
Esomeprazole (as esomeprazole magnesium) 40 mg oral capsule |
| Esophageal motility disorder |
Diffuse spasm of esophagus |
| Esophagospasm |
Diffuse spasm of esophagus |
| Esophagus TNM finding (finding) |
American Joint Committee on Cancer allowable value |
FHIR